South Korea vs North Macedonia: Tuberculosis treatment success rate in new and relapsed cases
South Korea
79
in 2023
North Macedonia
79
in 2023
South Korea rank
126th
North Macedonia rank
126th
Tuberculosis treatment success rate in new and relapsed cases over time
- South Korea
- North Macedonia
How they compare
South Korea currently reports 79 against 79 in North Macedonia, a difference of 0.
The two have swapped places 9 times across 27 shared years of data; in 1995 it was South Korea ahead.
South Korea ranks 126th and North Macedonia ranks 126th of 206 countries.
Across the 4 decades both report, South Korea averaged higher in 1 and North Macedonia in 3.
Head to head by decade
| Decade | South Korea | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 76.33 | 77.67 | 1.33 | North Macedonia |
| 2000s | 82.3 | 84.8 | 2.5 | North Macedonia |
| 2010s | 83.3 | 87.6 | 4.3 | North Macedonia |
| 2020s | 79.75 | 77.25 | 2.5 | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate in new and relapsed cases, South Korea or North Macedonia?
- South Korea, at 79 against 79 in North Macedonia as of 2023.
- What is the difference in tuberculosis treatment success rate in new and relapsed cases between South Korea and North Macedonia?
- 0, with South Korea ahead.
- How many years of comparable data are there for South Korea and North Macedonia?
- 27 years are reported by both, from 1995 to 2023.
- How do South Korea and North Macedonia rank globally for tuberculosis treatment success rate in new and relapsed cases?
- South Korea ranks 126th and North Macedonia ranks 126th of 206 countries.
- Where does this data come from?
- Our World in Data, published as Tuberculosis treatment success rate in new and relapsed cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.